Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Terminated

Proteus 235 and Proteus ONE proton therapy systems

FDA Recall Z-2672-2017 · Posted None

Recall StatusTerminated
Product CodeLHN
Date Initiated2016-05-18
Date Terminated2019-02-08
Product Quantity18 worldwide and 10, in the U.S.

Reason for Recall

Recall is being initiated to address on-site software installations not being performed consistently with IBA standard operating procedures.

Firm Action

An Urgent Field Safety Notice MID-54097 was mailed to affected customers to inform that IBA plans to deploy a new software by March 2017 to correct the issue. Customers were reminded to follow standard protocol until the software updates are deployed.

Root Cause

Employee error

Distribution Pattern

Products distributed to FL, VA, PA, OK, IL, NJ, WA, TN, LA, TX, South Korea, Germany, France, Czech Republic, Italy, Poland, and Sweden

Official Source

View FDA Recall →

Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.

↑